BioGaia’s subsidiary IBT has US IND open and Swedish

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
BioGaia’s subsidiary IBT has US IND open and Swedish CTA¹ approved for clinical study

Infant Bacterial Therapeutics (IBT), a subsidiary of BioGaia, today announced that the IND (Investigational New Drug) for the prevention of necrotizing enterocolitis (NEC), has been accepted by the FDA (U.S. Food and Drug Administration). Furthermore, IBT has received approval from the MPA (Medical Product Agency) to conduct its clinical trial in Sweden. IBT now has an open IND accepted by the FDA, which is an important step in allowing IBT to start clinical studies in the US. Furthermore, the Swedish MPA has given approval to IBT to conduct its clinical trial in Sweden. In addition to the approval by MPA, IBT has also received approval from the Ethical Committee. In November 2013 BioGaia founded the subsidiary IBT to manage the development of a pharmaceutical for the prevention of NEC, as this was not within BioGaia’s core business activities. IBT will now commence clinical development of its drug to prevent necrotizing enterocolitis (NEC) in Sweden and the US. NEC is a bowel disease, which affects premature infants and often is fatal. “We are very happy to see that IBT has reached these important milestones. This confirms that IBT:s drug development to date meets the requirements of both agencies to begin clinical trials in premature infants, the most vulnerable of all humans”, says Peter Rothschild, President, BioGaia and Chairman of the IBT board. “We are now able to conduct clinical trials both in the US and in an EU country and we are naturally excited to move on with our drug development with the aim of satisfying the global need to find a preventive therapy for NEC”, says Staffan Strömberg, President, Infant Bacterial Therapeutics. 1) Clinical Trial Application Latest press releases from BioGaia 2015-12-01 BioGaia makes further investments in MetaboGen 2015-10-26 BioGaia signs exclusive agreement in Sri Lanka 2015-10-23 BioGaia AB Interim Management statement 1 January – 30 September 2015 BioGaia has published this information in accordance with the Swedish Securities Market Act. The information was issued for publication on 8 January 2016, 02:00 pm CET. For additional information please contact Peter Rothschild, CEO, BioGaia: +46 8 555 293 00 Staffan Strömberg, CEO, IBT: +46 8 410 145 55 BioGaia is a healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri, which has probiotic, health -enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap list of the NASDAQ OMX Nordic Exchange Stockholm. www.biogaia.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Venue Two Eleven: Historic Charm Meets Modern Events

Updated Category News Views 8

Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...

Continue Reading
Workday Hits High Note in 2026 Gartner Magic Quadrant

Updated Category News Views 3

Workday Secures Leadership Position In a wild ride that's left investors with whiplash in recent years, Workday (NASDAQ: WDAY) has firmly planted its flag at the top tier of the 2026 Gartner® Magic Quadrant™ for Cloud ERP Finance. This announcement out of Pleasanton, California, resonates like a victory bell for the company's finance management solutions—a mix of AI,...

Continue Reading
Coastal Financial Faces Lawsuit Over Fraud Allegations

Updated Category News Views 2

Coastal Financial Corporation, riding high on NASDAQ as CCB, now finds itself in the middle of a storm. Schall, Brown & Schwartz LLP, a firm known for its shareholder rights litigation, has thrown the gauntlet with a class action lawsuit against Coastal for suspected securities violations. We're talking about potential fibs under Section 10(b) and 20(a) of the Securities...

Continue Reading
Understanding Truck Accident Settlements in Memphis

Updated Category News Views 1

Delving into Truck Accident Settlement Timelines Out there in Memphis, timing a truck accident settlement isn't exactly like clockwork work. When it comes to getting your compensation, the timeline varies as widely as a duck hunting trip—sometimes you come home with a basketful, sometimes it’s empty. It might be a quick couple of months or drag on past a year, and...

Continue Reading
LINC Lawsuit: Boardroom Stumbles Spark Investor Action

Updated Category News Views 4

Class Action Kickoff: Lincoln's Educational Curveball No one fancies home runs when the ball’s out of sight, and that’s probably how some investors in Lincoln Educational Services Corporation (NASDAQ: LINC) are feeling right now. A group of shareholders has pulled back the curtain on what they believe are more than just administrative hiccups—allegations of...

Continue Reading
Navigating Braces vs. Invisalign: Key Considerations

Updated Category News Views 0

Choice Between Braces and Invisalign Isn't Straightforward When you're pondering over whether to go with braces or Invisalign, it ain't just a choice you make lightly over coffee. It's a nuanced decision that hinges on a multitude of factors as highlighted by orthodontic experts Dr. Erik Higginbottom and Dr. Kyle Higginbottom from Easton, MD, featured in HelloNation's...

Continue Reading
Noé Hinojosa Jr. Honored for Leadership in Business

Updated Category News Views 3

From Bonds to Ballgames: Hinojosa's Impact Listen up, because this one’s more than just another accolade on a shelf. Noé Hinojosa Jr., a big gun over at TRB Securities, is getting the 2026 Hispanic Business Salute Award, and it's a doozy. Awarded by all the big wigs—UPS, NBC 5, Telemundo 39, and the Dallas Cowboys—this isn't a small pat on the back. It's a full-on...

Continue Reading
Netcapital Faces Securities Fraud Claims: Key Investor Notes

Updated Category News Views 0

Netcapital Under Fire: The Suit Unfolds You ever see a stock go through such highs and lows that you wish you had popcorn on standby? Well, that's where Netcapital Inc. (NASDAQ: NCPL) is sitting right now, in the midst of a class action lawsuit that's got investors' heads spinning. The accusations are serious: false and misleading statements about revenues that seem to...

Continue Reading
Encompass Health: Leader in Rehabilitation Again in 2026

Updated Category News Views 1

Pinnacle of Rehab: Encompass Health's Notable Streak You know, in a world where healthcare accolades fly around like confetti, Encompass Health Corp's persistence in being named America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek for the seventh straight year is something to chew on. The fact that a record 78 of its hospitals dotted across 32 states...

Continue Reading
AI-Designed Antivirals: A Brave New World

Updated Category News Views 7

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking Mineral Potential in Oman with Advanced Tech Solutions

Updated Category News Views 74

Exploring Mineral Potential in Oman with Innovative Technology Viridien has launched an exciting initiative to enhance mineral exploration in Oman. Selected by Minerals Development Oman (MDO), the company is set to conduct a comprehensive remote sensing program over seven concessions that cover an impressive 16,000 km². This effort demonstrates Viridien's dedication to...

Continue Reading
Enfuse Group Achieves Milestone as a Certified B Corporation

Updated Category News Views 122

Enfuse Group Becomes a Certified B Corporation Enfuse Group is making waves in the consultancy world, emphasizing the importance of both excellence and responsibility. This award-winning digital transformation consultancy is thrilled to share that it has earned the prestigious title of a Certified B Corporation. This certification underscores their commitment to positive...

Continue Reading
Collegium Pharmaceutical Insider Selling Alert: What It Means

Updated Category News Views 100

Recent Insider Activity at Collegium Pharmaceutical Recently, significant insider trading activity has transpired at Collegium Pharmaceutical, a notable player in the pharmaceutical sector. John G. Freund, MD, who serves as a director within the company, sold a substantial portion of his shares. This event surfaced through an SEC Form 4 filing, drawing attention from...

Continue Reading
AirTurn Launches MAV: The Perfect Bluetooth Solution for Adventurers

Updated Category News Views 235

Revolutionizing Outdoor Adventures with AirTurn MAV In today's fast-paced world, finding ways to simplify our lives while enjoying outdoor adventures is essential. AirTurn, a pioneer in wireless control solutions, has just unveiled the AirTurn MAV — a wear-resistant and waterproof Bluetooth controller designed specifically for outdoor activities. This innovation caters...

Continue Reading
Bragg Gaming's Expansion into Brazil's iGaming Market

Updated Category News Views 133

Bragg Gaming's Entrance into Brazil's iGaming Landscape Bragg Gaming Group (NASDAQ: BRAG, TSX: BRAG), a prominent provider of innovative iGaming content and platform technology solutions, proudly announces its official launch in Brazil's regulated online casino market. This follows Brazil's exciting move to enact regulated online casino operations, marking a significant...

Continue Reading